Supplier · public contract awards

Takeda GmbH public contracts.

Takeda GmbH has won 143 public contracts between 2017 and 2026 from 20 public buyers in Germany. Its most frequent buyer is IKK classic (26 awards). Outside TED, published values total €6.2 million across 9 awards. 72 awards were published on TED; the median contract size is about €210,000 (6 contracts with a value).

143Contracts won
20Public buyers
1Country
May 2026Latest award

Latest contracts won

Németország – Gyógyszerészeti termékek – Bekanntmachung vergebener Aufträge nach §130 a Abs. 8 SGB V zu den Präparaten Leuprorelin (DIS / RMS)
Awarded by GWQ ServicePlus AG · Germany
27 May 2026Awarded
Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu Arzneimitteln zur Behandlung der Hämophilie
Awarded by AOK Sachsen - Anhalt · Germany
31 Aug 2023Awarded
Ex-post-Transparenzbekanntmachung Vertrag gem. § 130a iVm 130c SGB V (Blutgerinnungsfaktor VII & IX (human)_Nonacog gamma_Octocog & Vonicog alfa_..._T
Awarded by AOK Nordost - Die Gesundheitskasse · Germany
3 Aug 2023Awarded
Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der Takeda GmbH zu Entyvio(R)
Awarded by IKK classic · Germany
28 Jun 2023Awarded
Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130a Abs. 8 SGB V zwischen der IKK classic und der Takeda GmbH zu Natpar(R)
Awarded by IKK classic · Germany
5 Sep 2022Awarded
Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der Takeda GmbH zu Alofisel(R) (Darvadstrocel)
Awarded by IKK classic · Germany
2 Dec 2021Awarded
Ex-Ante-Transparenzbekanntmachung Vertrag gem. § 130a Abs. 8 i.V.m. § 130c Abs. 1 SGB V zu dem Arzneimittel Veyvondi (ATC-Code B02BD40)
Awarded by AOK Sachsen - Anhalt · Germany
20 Sep 2021Awarded
Ex-Ante-Transparenzbekanntmachung Vertrag gem. § 130a Abs. 8 i.V.m. § 130c Abs. 1 SGB V zu dem Arzneimittel Rixubis ( ATC-Code B02BD29)
Awarded by AOK Sachsen - Anhalt · Germany
20 Sep 2021Awarded
Ex-Ante-Transparenzbekanntmachung Vertrag gem. § 130a Abs. 8 i.V.m. § 130c Abs. 1 SGB V zu dem Arzneimittel Recombinate ( ATC-Code B02BD15)
Awarded by AOK Sachsen - Anhalt · Germany
20 Sep 2021Awarded
Ex-Ante-Transparenzbekanntmachung Vertrag gem. § 130a Abs. 8 i.V.m. § 130c Abs. 1 SGB V zu dem Arzneimittel Immunine ( ATC-Code B02BD04)
Awarded by AOK Sachsen - Anhalt · Germany
20 Sep 2021Awarded

Contracts won by year

Contracts won by year

from the published records
20172
20192
202122
20222
20236
20261

Published value, by currency (feeds other than TED)

EUR · 9 valued
€6.2 million

Typical contract size on TED

EUR · median of 6 contracts
€210,000

From published award records. Suppliers are matched by legal name; a company with a different legal name in another country (a national subsidiary, for example) has its own page. Each currency is shown on its own and never converted. TED values are often framework ceilings, so TED awards show a median contract size, never a total.

Bid with askTender

Bidding against Takeda GmbH?

askTender reads every open tender against your company profile — eligibility, the gaps, and the documents you need — and can prepare the entire bid.

Start bidding See open tenders